Mark H. Moss, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Mark Moss is the Director of the Clinical Research Program in the Division of Allergy and Immunology. His medical interests include asthma, rhinitis and atopic dermatitis.
Specialties
Clinics
West Clinic
(608) 263-6180 | (800) 323-8942 | Map
UW School of Medicine and Public Health
Department of Pediatrics |
Department of Medicine |
Professional Certifications and Education
Fellowship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
Residency |
University of Wisconsin Hospital and Clinics, Madison, WI
|
Internship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
Medical School |
University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI
|
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
Research |
Dr. Moss’ research interests include childhood asthma, allergic rhinitis and allergy immunotherapy. |
PubMed Articles
-
McIntyre AP Viswanathan RK Moss MH Mathur SK
Real-world dosing of omalizumab for chronic spontaneous urticaria. Ann Allergy Asthma Immunol . 2020 Feb;124(2):211-212
[PubMed ID: 31805358]
-
Viswanathan RK Moss MH Mathur SK
Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria. Allergy Asthma Proc . 2013 Sep-Oct;34(5):446-52
[PubMed ID: 23998242]
-
Thomas A Moss MH
Children at risk for food-related anaphylaxis should carry two doses of epinephrine. J Pediatr . 2010 Nov;157(5):861
[PubMed ID: 20955858]
-
Lemanske RF Jr Mauger DT Sorkness CA Jackson DJ Boehmer SJ Martinez FD Strunk RC Szefler SJ Zeiger RS Bacharier LB Covar RA Guilbert TW Larsen G Morgan WJ Moss MH Spahn JD Taussig LM Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute.
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med . 2010 Mar 18;362(11):975-85
[PubMed ID: 20197425]
-
Sorkness CA Lemanske RF Jr Mauger DT Boehmer SJ Chinchilli VM Martinez FD Strunk RC Szefler SJ Zeiger RS Bacharier LB Bloomberg GR Covar RA Guilbert TW Heldt G Larsen G Mellon MH Morgan WJ Moss MH Spahn JD Taussig LM Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol . 2007 Jan;119(1):64-72
[PubMed ID: 17140647]
-
Moss MH
Immunotherapy: first do no harm. Immunol Allergy Clin North Am . 2005 May;25(2):421-39, viii
[PubMed ID: 15878464]